(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USOS DE TRANSGENES, E VETOR VIRAL RECOMBINANTE

ArquivadaInvention PatentPCT · US2018058307

Application data

Number

112021002332

Type

Invention Patent

Filing

10/30/2018

Publication

05/11/2021

PCT

US2018058307

Progress at the INPI

  1. Filing10/30/18
  2. Publication05/11/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 04/08/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

LOGICBIO THERAPEUTICS, INC.

US

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES

US

Inventors

B. C. (pessoa física)

US

C. V. (pessoa física)

US

J. L. (pessoa física)

US

K. C. (pessoa física)

US

R. C. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/717,771 · 08/10/2018

Abstract

TERAPIA GÊNICA NÃO-DISRUPTIVA PARA O TRATAMENTO DE MMA. A presente invenção refere-se a métodos e tecnologias para o tratamento da acidemia metilmalônica.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

04/08/2025

RPI 2831

Parecer de pré-exame

#6.23

07/02/2024

RPI 2791

Notificação de entrada na fase nacional - PCT

#1.3

05/11/2021

RPI 2627

Alteração de dados cadastrais

#1.1

02/23/2021

RPI 2616

Related

From the same holder

Same category

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.